Gil Beyen
Director/Board Member bij PHAXIAM THERAPEUTICS S.A.
Vermogen: 1 590 $ op 29-02-2024
Profiel
Gil Beyen founded TiGenix NV.
He is Executive Chairman at Erytech Pharma, Inc. and Co-Managing Director at Axxis V&C BVBA.
Mr. Beyen is also Commissioner for Vlaams Instituut voor Biotechnologie - Flanders Institute and on the board of 6 other companies.
In the past Gil Beyen occupied the position of MD, Executive Director & Chief Business Officer at TiGenix NV, Head-Life Sciences Division at Arthur D.
Little, Inc. and Head-Life Sciences Division at Arthur D.
Little Benelux NV (a subsidiary of Arthur D.
Little, Inc.), Chief Executive Officer & Director at ERYTech Pharma SA and Manager of Gil Beyen BVBA.
He received an MBA from The University of Chicago, a graduate degree from Université Catholique de Louvain and a graduate degree from Katholieke Universiteit Leuven.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
28-03-2023 | 484 ( 0.01% ) | 1 590 $ | 29-02-2024 |
Actieve functies van Gil Beyen
Bedrijven | Functie | Begin |
---|---|---|
PHAXIAM THERAPEUTICS S.A. | Director/Board Member | 23-06-2023 |
Erytech Pharma, Inc.
Erytech Pharma, Inc. BiotechnologyHealth Technology Erytech Pharma, Inc. operates as a biopharmaceutical company. The private company is based in Cambridge, MA. | Chairman | - |
Waterleau NV
Waterleau NV Water UtilitiesUtilities Waterleau NV engages in the provision of water technology services. It offers solutions for water, wastewater, air, and new energy. Its solutions are designed for managing the complete water cycle from process water and drinking water production, over wastewater treatment and discharge compliance to energy, water and nutrient recovery. The company was founded by Luc Vriens, Eddy Frans, Jean-Marie Ghislain, Willy Gils, Ron Gerards and Bernard Lemaitre in 2000 and is headquartered in Wespelaar, Belgium. | Director/Board Member | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Director/Board Member | 15-12-2014 |
Axxis V&C BV
Axxis V&C BV Miscellaneous Commercial ServicesCommercial Services Axxis V&C BVBA provides business and management consulting services. The private company is based in Haasrode, Belgium. The CEOs are Willem Beyen, Nadine Buyle, Gil Beyen. The Belgian company was founded in 1998. | Chief Executive Officer | - |
Belgian Association for Bioindustries | Director/Board Member | - |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | 14-10-2010 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Director/Board Member | 14-10-2010 |
Ecloosion SA | Director/Board Member | 14-10-2010 |
Eerdere bekende functies van Gil Beyen
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░ ░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Gil Beyen
The University of Chicago | Masters Business Admin |
Katholieke Universiteit Leuven | Graduate Degree |
Université Catholique de Louvain | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PHAXIAM THERAPEUTICS S.A. | Health Technology |
Bedrijven in privébezit | 13 |
---|---|
TiGenix NV
TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
Waterleau NV
Waterleau NV Water UtilitiesUtilities Waterleau NV engages in the provision of water technology services. It offers solutions for water, wastewater, air, and new energy. Its solutions are designed for managing the complete water cycle from process water and drinking water production, over wastewater treatment and discharge compliance to energy, water and nutrient recovery. The company was founded by Luc Vriens, Eddy Frans, Jean-Marie Ghislain, Willy Gils, Ron Gerards and Bernard Lemaitre in 2000 and is headquartered in Wespelaar, Belgium. | Utilities |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Axxis V&C BV
Axxis V&C BV Miscellaneous Commercial ServicesCommercial Services Axxis V&C BVBA provides business and management consulting services. The private company is based in Haasrode, Belgium. The CEOs are Willem Beyen, Nadine Buyle, Gil Beyen. The Belgian company was founded in 1998. | Commercial Services |
Gil Beyen BVBA | Commercial Services |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Commercial Services |
Belgian Association for Bioindustries | |
Ecloosion SA | |
Arthur D. Little Benelux NV/SA
Arthur D. Little Benelux NV/SA Miscellaneous Commercial ServicesCommercial Services Arthur D. Little Benelux NV SA is a global management consultancy specializing in strategy and operations management, serving major corporations and organizations worldwide. They are recognized as leaders in linking strategy, innovation and technology to solve their clients' most complex business issues, delivering sustainable solutions. They are distinguished from others by their deep industry insight and technology expertise. The company was founded in 1967 and is headquartered in Brussels, Belgium. | Commercial Services |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
Bio.Be SA | |
Erytech Pharma, Inc.
Erytech Pharma, Inc. BiotechnologyHealth Technology Erytech Pharma, Inc. operates as a biopharmaceutical company. The private company is based in Cambridge, MA. | Health Technology |